The joint pain that showed up in my late 40s felt so disconnected from everything else that was happening — hot flushes, sleep chaos, the brain fog. It took years before anyone joined the dots back to oestrogen. If you're waking up stiff, finding your fingers swollen, or noticing your knees have opinions about stairs now, please know this is not just 'wear and tear' and it is absolutely not in your head.
Learn more about Rose →Chondrocytes — the cells responsible for maintaining and repairing cartilage — carry both estrogen receptor alpha and beta, meaning cartilage is not a passive bystander to hormonal change. When estrogen binds to these receptors, it stimulates the production of collagen and proteoglycans, the structural proteins that keep cartilage resilient and hydrated. Once estrogen falls, that maintenance signal is withdrawn and cartilage begins to break down faster than it can repair itself.
The synovial membrane lining every joint also contains estrogen receptors, and it relies on estrogen signalling to produce thick, lubricating synovial fluid. As estrogen declines, the viscosity and volume of this fluid can decrease, reducing the joint's ability to absorb impact and distribute load evenly across cartilage surfaces. The result is increased friction during everyday movement — which over time contributes directly to cartilage erosion.
Estrogen acts as a systemic anti-inflammatory agent, partly by suppressing pro-inflammatory cytokines like interleukin-1 and TNF-alpha. After menopause, this brake on inflammation is loosened, and low-grade systemic inflammation rises — a state sometimes called inflammaging. Inside joints, this chronic inflammatory environment accelerates the enzymatic breakdown of cartilage matrix and contributes to the synovial inflammation that makes osteoarthritis progressively more painful.
Healthy cartilage depends on the subchondral bone beneath it for structural support, and this bone layer is exquisitely sensitive to estrogen. As estrogen falls and bone turnover accelerates, the subchondral bone can become both stiffer and less even, altering the mechanical forces transmitted through joints during loading. This changed mechanical environment sends damaging signals to chondrocytes above, contributing to cartilage thinning even before significant bone density loss shows up on a DEXA scan.
Estrogen supports muscle protein synthesis and helps maintain muscle mass, so its decline contributes to the accelerated sarcopenia many women notice in their late 40s and 50s. Muscle surrounding joints — particularly the quadriceps around the knee — acts as a shock absorber, and when that mass decreases, joints absorb more direct mechanical stress with every step. The combination of reduced cartilage resilience and reduced muscular protection creates a compounding vulnerability that ordinary age-related muscle loss alone does not explain.
Menopause drives a shift in fat distribution from the hips and thighs toward the abdomen, and this central weight gain — even without a significant change on the scales — increases mechanical load through the knees, hips, and lumbar facet joints. Every extra kilogram of body weight is estimated to add approximately four kilograms of force across the knee during walking. This load amplification effect means that even modest increases in central adiposity after menopause can meaningfully accelerate cartilage wear.
Cartilage has no blood supply of its own and depends on the pressure changes of rest and movement to draw in nutrients and expel waste products — a process that is most efficient during sleep. The sleep disruption that is one of menopause's most consistent symptoms interrupts this overnight maintenance cycle, reducing the joint's capacity to recover from daily mechanical loading. Research also shows that poor sleep independently elevates inflammatory markers, compounding the pro-inflammatory environment already created by estrogen loss.
Estrogen modulates pain pathways in the central nervous system, and its withdrawal lowers the pain threshold — meaning the same degree of joint damage produces more pain than it would have premenopausally. This phenomenon, sometimes called central sensitisation, can make osteoarthritis feel more severe than imaging alone would predict, and it explains why some women in perimenopause report significant joint pain before any structural damage is visible on X-ray or MRI. The pain is real; the nervous system is simply louder.
Erosive hand osteoarthritis — affecting the small interphalangeal joints of the fingers — shows a sharp incidence peak in women at perimenopause that has no equivalent in men of the same age, strongly implicating estrogen withdrawal as a specific trigger. Women often notice swelling, redness, and bony nodules forming at the finger joints (Heberden's and Bouchard's nodes) within a few years of their final period. Unlike knee or hip osteoarthritis, this pattern of joint involvement is now considered a recognised menopausal symptom in its own right, not merely coincidental aging.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.